Sanofi

Holdings as of Sep 30, 2026 · filed Nov 5, 2026

$629867590
Portfolio value
16
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Meiragtx Holdings Plc $134175107 21.30% — Held
2 Inhibrx Biosciences, Inc. $115885234 18.40% — Held
3 Novavax $74378000 11.81% — Held
4 Korsana Biosciences $63808352 10.13% — NEW BUY
5 Odyssey Therapeutics Inc. $44222244 7.02% -1718 -0.09%
6 Anaptysbio $41309548 6.56% — Held
7 Agomab Therapeutics Nv $30892366 4.90% — Held
8 First Tracks Biotherapeutics Inc. $29128738 4.62% — Held
9 Electra Therapeutics Inc $27696915 4.40% — NEW BUY
10 Attovia Therapeutics Inc $18560135 2.95% — NEW BUY
11 Latigo Biotherapeutics Inc $11235393 1.78% — NEW BUY
12 Immuneering Corp $11091549 1.76% — Held
13 Maplight Therapeutics Inc. $9293698 1.48% — Held
14 Scribe Therapeutics $9202500 1.46% — NEW BUY
15 Sab Biotherapeutics Inc $6969245 1.11% — NEW BUY
16 Q32 Bio Inc. $2018566 0.32% — Held

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.